Pacific Biosciences of California Inc (PACB)
1.36
-0.11
(-7.48%)
USD |
NASDAQ |
Apr 24, 16:00
1.37
+0.01
(+0.74%)
After-Hours: 20:00
Pacific Biosciences of California Revenue (Annual): 200.52M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 200.52M |
| December 31, 2022 | 128.30M |
| December 31, 2021 | 130.51M |
| December 31, 2020 | 78.89M |
| December 31, 2019 | 90.89M |
| December 31, 2018 | 78.63M |
| December 31, 2017 | 93.47M |
| December 31, 2016 | 90.71M |
| December 31, 2015 | 92.78M |
| Date | Value |
|---|---|
| December 31, 2014 | 60.59M |
| December 31, 2013 | 28.18M |
| December 31, 2012 | 25.98M |
| December 31, 2011 | 33.86M |
| December 31, 2010 | 1.674M |
| December 31, 2009 | 0.135M |
| December 31, 2008 | 0.901M |
| December 31, 2007 | 2.163M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
78.89M
Minimum
2020
200.52M
Maximum
2023
125.82M
Average
128.30M
Median
2022
Revenue (Annual) Benchmarks
| Cerus Corp | 156.37M |
| Axogen Inc | 159.01M |
| AVITA Medical Inc | 50.14M |
| BioSig Technologies Inc | 0.018M |
| Intellia Therapeutics Inc | 36.28M |